Biopharmaceutical research companies are conducting or have conducted more than 3,400 clinical trials of new medicines in collaboration with the state’s clinical research centers, university medical schools and hospitals (1999 to present).

Of the more than 3,400 clinical trials, more than 1,500 target the nation’s six most debilitating chronic diseases—asthma, cancer, diabetes, heart disease, mental illnesses and stroke.

“The clinical trials biopharmaceutical companies have conducted in the Commonwealth have benefited not only patients, but also the state’s economy. They’ve been a boost to the economies of communities all over Virginia because the companies hire local research institutions —including university medical schools and community hospitals—to conduct the trials for them. And that has given these research centers an opportunity to be involved in challenging, cutting-edge science and a steady source of revenue.” --Paul Miller, Chairman, Virginia Small Business Partnership